Older studies showed more favorable course with significant renal recovery after initiating dialysis [6,7,34], but more recent reports concluded that renal prognosis is comparable to anti-GBM disease and is worse compared to patients with anti-MPO antibodies [10,11]. The gene discussed is MPO; the disease is glioblastoma.